VAGISTAT-1 Drug Patent Profile
✉ Email this page to a colleague
When do Vagistat-1 patents expire, and when can generic versions of Vagistat-1 launch?
Vagistat-1 is a drug marketed by Combe and is included in one NDA.
The generic ingredient in VAGISTAT-1 is tioconazole. There are three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tioconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vagistat-1
A generic version of VAGISTAT-1 was approved as tioconazole by PERRIGO on November 21st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VAGISTAT-1?
- What are the global sales for VAGISTAT-1?
- What is Average Wholesale Price for VAGISTAT-1?
Summary for VAGISTAT-1
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Patent Applications: | 4,636 |
| DailyMed Link: | VAGISTAT-1 at DailyMed |
US Patents and Regulatory Information for VAGISTAT-1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combe | VAGISTAT-1 | tioconazole | OINTMENT;VAGINAL | 020676-001 | Feb 11, 1997 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
